Formulation - BioPharm International


Oral tablets & capsules. Solutions, suspensions, injectables, as well as topical ointments, gels & solutions. Lyophilization (freeze drying), spray drying, hot-melt extrusion & nanocrystal technology.

FDA Issues Guidance on Expedited Programs for Serious Conditions

May 30, 2014

FDA finalizes guidance on expedited programs for new drug approvals for treatment of serious and life-threatening conditions.

BIO and ViS Research Help Streamline Pediatric Clinical Trials

May 8, 2014

The Pediatric Clinical Research Group initiative expands to include pediatric research sites.

Novel Vaccine Technologies Meet the Need for Pandemic and Therapeutic Solutions

May 1, 2014

New approaches to vaccine production are targeting rapid supply for pandemic situations and broadly effective therapeutic treatments.

Implications of Trace Levels of Redox-Active Metals in Drug-Product Formulation

April 1, 2014

The presence of minute amounts of chelators can help minimize the degradation of monoclonal antibodies.

FDA Details National Vaccine Plan

March 11, 2014

HHS plan makes progress in ensuring availability of safe vaccines.

National Cancer Institute Announces Genetic Sequencing Trial

January 30, 2014

NCI launches trial to assess the utility of genetic sequencing to improve patient outcomes.

Challenges and Strategies for the Downstream Purification and Formulation of Fab Antibody Fragments

January 1, 2014

Antibody fragments pose unique challenges in recovery, purification, and formulation.



Click here